Glimepiride & Metformin HCI (SR) Tablets I.P.

Glytrex M1, manufactured by Pacitora Biotech, is a dual-action prescription medication specifically formulated for the management of Type 2 Diabetes Mellitus. It combines two potent anti-diabetic agents: Glimepiride, a sulfonylurea that stimulates the pancreas to produce more insulin, and Metformin Hydrochloride (Sustained Release), a biguanide that improves insulin sensitivity and reduces glucose production in the liver.

Key Benefits:

• Dual Control: Effectively lowers both fasting and post-meal blood sugar levels.
• Sustained Release: SR technology ensures long-lasting action and better stomach tolerance.
• Improved Insulin Sensitivity: Helps the body utilize natural insulin more efficiently.
• Liver Support: Reduces excess glucose production by the liver.
• Certified Quality: Manufactured in GMP and ISO-certified facilities for guaranteed purity.

FAQs:

1. What is Glytrex M1 used for?

Glytrex M1 is used to control high blood sugar levels in adults with Type 2 Diabetes Mellitus when diet and exercise alone are insufficient.

2. How does the Sustained Release (SR) mechanism help?

The SR formulation releases the medication slowly, maintaining steady blood levels and significantly reducing the risk of digestive side effects.

3. Can I take Glytrex M1 on an empty stomach?

It is generally recommended to take this medication with food to minimize stomach discomfort and optimize the absorption of Metformin.

4. Are there any common side effects?

Common side effects may include low blood sugar (hypoglycemia), nausea, or a metallic taste; consult your doctor if these persist.

5. Is Glytrex M1 safe for long-term use?

Yes, it is designed for chronic management of diabetes, provided you undergo regular check-ups and follow your physician’s guidance.